ORPHAN DRUG CONSULTING HOLDING LIMITED

Orphan Drug Consulting is a specialist consultancy that guides pharmaceutical and biopharmaceutical companies through every stage of the orphan‑drug and rare‑disease product launch lifecycle. Drawing on more than 200 years of combined experience in supply‑chain and quality‑assurance, the firm provides end‑to‑end support—from strategic advice and corporate development to regulatory affairs, vendor management and post‑launch optimisation—ensuring that innovative therapies reach patients across the EU, the US and global markets.

The company’s cross‑functional expertise covers supply‑chain design, quality‑assurance leadership, expanded‑access programmes in over 100 countries, finance and entity structuring, customs and VAT compliance, pharmacovigilance, and organisational design. Its team of highly qualified specialists works closely with clients, offering tailored, phase‑appropriate solutions that align with each timetable and objective, without hard‑selling.

With offices in Dublin and Boston, Orphan Drug Consulting combines a “do it right, first time every time” culture with relationships built on trust, delivering agile, cost‑effective pathways to market for innovative orphan‑drug developers.